Latest Food and Drug Administration Stories
Levinson To Present "How To Turn FLMA Into Your Competitive Advantage" CHICAGO, Jan.
WASHINGTON, Jan. 13, 2015 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L.
- Products to be Marketed to Clinics and Hospitals across the United States - DUBLIN, Jan.
HORSHOLM, Denmark, Jan. 13, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) (Veloxis) today confirmed that it has received notice from the U.S.
MENLO PARK, Calif., Jan.
LAKE FOREST, Ill., Jan.
ALBANY, N.Y., Jan.
Companies Committed to Providing Access to Colchicine Tablets CINCINNATI and DEERFIELD, Ill., Jan.
MONTREAL, Jan. 12, 2015 /PRNewswire/ - Milestone Pharmaceuticals, Inc. announced today that it received clearance of its Investigational New Drug (IND) Application from the U.S.
NEW YORK, Jan. 9, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AMAG Pharmaceuticals, Inc. ("AMAG" or the "Company").
Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.